Boyun Shi

606 total citations
16 papers, 439 citations indexed

About

Boyun Shi is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Boyun Shi has authored 16 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Boyun Shi's work include Cancer-related molecular mechanisms research (5 papers), Autophagy in Disease and Therapy (4 papers) and MicroRNA in disease regulation (3 papers). Boyun Shi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Autophagy in Disease and Therapy (4 papers) and MicroRNA in disease regulation (3 papers). Boyun Shi collaborates with scholars based in China, United States and Hong Kong. Boyun Shi's co-authors include Xinke Zhou, Min Liang, Leyuan Liu, Jifang Liu, Yue Fei, Jitao Chen, Guibin Xu, Guifang Yu, Xianhan Jiang and Jian Wang and has published in prestigious journals such as Hepatology, Oncogene and Scientific Reports.

In The Last Decade

Boyun Shi

16 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boyun Shi China	13	317	206	80	72	44	16	439
Xiaoqing Luo China	6	281 0.9×	243 1.2×	138 1.7×	75 1.0×	48 1.1×	16	540
Tianwei Chen China	11	247 0.8×	133 0.6×	55 0.7×	87 1.2×	53 1.2×	25	421
Zhicong Zhao China	13	524 1.7×	280 1.4×	115 1.4×	65 0.9×	36 0.8×	39	710
Heqing Yi China	12	215 0.7×	154 0.7×	109 1.4×	68 0.9×	37 0.8×	25	418
Chung‐Wah Wu Hong Kong	7	350 1.1×	231 1.1×	91 1.1×	49 0.7×	28 0.6×	12	467
Shun-Fa Yang Taiwan	14	348 1.1×	180 0.9×	53 0.7×	112 1.6×	31 0.7×	21	496
Yaliang Lan China	9	360 1.1×	296 1.4×	45 0.6×	77 1.1×	55 1.3×	12	526
Aristeidis E. Boukouris Canada	8	331 1.0×	129 0.6×	46 0.6×	99 1.4×	38 0.9×	13	493
Chengdong Qin China	10	358 1.1×	303 1.5×	31 0.4×	105 1.5×	45 1.0×	19	545

Countries citing papers authored by Boyun Shi

Since Specialization

Citations

This map shows the geographic impact of Boyun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyun Shi more than expected).

Fields of papers citing papers by Boyun Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyun Shi. The network helps show where Boyun Shi may publish in the future.

Co-authorship network of co-authors of Boyun Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Boyun Shi. A scholar is included among the top collaborators of Boyun Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyun Shi. Boyun Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Luo, Xiaodan, Le Qin, Robert Weinkove, et al.. (2024). Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma. Frontiers in Immunology. 15. 1497736–1497736. 2 indexed citations

Huang, Junting, Suying Lü, Xue‐Qun Luo, et al.. (2023). A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analysis. Cancer Medicine. 12(13). 14130–14137. 2 indexed citations

Shi, Boyun, Wei Wang, Min Liang, et al.. (2023). Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1S. Liver International. 43(6). 1307–1319. 12 indexed citations

Liang, Min, Wenxia Yao, Boyun Shi, et al.. (2021). Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging miR-127-5p and miR-136-5p. Cell Death and Disease. 12(7). 639–639. 47 indexed citations

Li, Wenjiao, Yuan Dai, Boyun Shi, et al.. (2020). LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas. Oncogene. 39(19). 3879–3892. 34 indexed citations

Liu, Pengfei, Montserrat Rojo de la Vega, Matthew Dodson, et al.. (2019). Spermidine Confers Liver Protection by Enhancing NRF2 Signaling Through a MAP1S‐Mediated Noncanonical Mechanism. Hepatology. 70(1). 372–388. 58 indexed citations

Liang, Min, Zhaoyu Liu, Hai Lin, et al.. (2019). High-throughput sequencing reveals circular RNA hsa_circ_0000592 as a novel player in the carcinogenesis of gastric carcinoma. Bioscience Reports. 39(6). 17 indexed citations

Huang, Guanqun, et al.. (2018). Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis. Cancer Management and Research. Volume 10. 5027–5041. 27 indexed citations

Huang, Guanqun, Hui Jiang, Ye Lin, et al.. (2018). lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. Cell Death and Disease. 9(5). 487–487. 31 indexed citations

10.

Li, Wenjiao, Yue Fei, Yuan Dai, et al.. (2018). Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation. Cell Death and Differentiation. 26(8). 1379–1395. 33 indexed citations

11.

Liang, Min, Wenxia Yao, Jifang Liu, et al.. (2017). Functional role of lncRNA LOC101927497 in N -methyl- N ′-nitro- N -nitrosoguanidine-induced malignantly transformed human gastric epithelial cells. Life Sciences. 193. 93–103. 19 indexed citations

12.

Shi, Boyun, et al.. (2017). Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma. BMC Cancer. 17(1). 414–414. 4 indexed citations

13.

Zhou, Xinke, Jitao Chen, Xiao Feng, et al.. (2017). Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts. Cancer Letters. 411. 1–11. 17 indexed citations

14.

Yu, Guifang, et al.. (2017). Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis. Scientific Reports. 7(1). 17176–17176. 18 indexed citations

15.

Liang, Min, Boyun Shi, Jifang Liu, et al.. (2015). Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients. Drug Design Development and Therapy. 9. 3607–3607. 29 indexed citations

16.

Zhou, Xinke, Jitao Chen, Min Deng, et al.. (2015). Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Oncotarget. 7(1). 873–884. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact